Maximum voluntary ventilation

Spirometric determinants in chronic obstructive pulmonary disease patients and normal subjects

Thomas A Dillard, O. W. Hnatiuk, T. R. McCumber

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The 12-s maximum voluntary ventilation (MVV) provides an estimate of the ventilatory reserves available to meet the physiologic demands of exercise. Earlier studies established a general relationship between MVV and FEV1. We hypothesized that the resting maximum inspiratory flow rate (MIFR) also serves as a clinically useful predictor of the MVV. A total of 105 subjects, 45 women and 60 men (age 57 ± 5 yr, mean ± SD), with expiratory impairment categories of severe (n = 26), moderate (n = 22), mild (n = 18), and normal (n = 39) based on FEV1 (percentage of predicted), comprised the study samples. The ratio MVV/FEV1 averaged 41 ± 7 overall. The FEV1 correlated with MVV in normal subjects (p < 0.05, r2 = 0.642) and patients (p < 0.05, r2 = 0.787) better than MIFR (p < 0.05, r2 ≥ 0.480). MIFR joined with FEV1 in multiple linear regression to significantly improve the description of MVV: MVV L/min = 30.77FEV1 (L) + 5.94MIFR (L/s) - 4.77 (n = 105; p < 0.05, r2 = 0.849). The 95% confidence limits for MVV varied from 90 to 110% of predicted from the equation for this sample. The factors sex and impairment category did not reduce the unexplained variability in MVV after inclusion of FEV1 and MIFR as covariates in ANOVA (p > 0.05). Addition of MIFR to the model with FEV1 produced greater improvement in r2 than PI(max). We conclude that MIFR, although secondary in importance to FEV1, is a significant determinant of MVV in patients with COPD and normal subjects. Estimation of MVV from FEV1 alone is less accurate than either direct measurement of MVV or estimation by inclusion of MIFR.

Original languageEnglish (US)
Pages (from-to)870-875
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume147
Issue number4
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Ventilation
Exercise

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Maximum voluntary ventilation : Spirometric determinants in chronic obstructive pulmonary disease patients and normal subjects. / Dillard, Thomas A; Hnatiuk, O. W.; McCumber, T. R.

In: American Review of Respiratory Disease, Vol. 147, No. 4, 01.01.1993, p. 870-875.

Research output: Contribution to journalArticle

@article{0703890abbb24f1c803cd3de98ab9644,
title = "Maximum voluntary ventilation: Spirometric determinants in chronic obstructive pulmonary disease patients and normal subjects",
abstract = "The 12-s maximum voluntary ventilation (MVV) provides an estimate of the ventilatory reserves available to meet the physiologic demands of exercise. Earlier studies established a general relationship between MVV and FEV1. We hypothesized that the resting maximum inspiratory flow rate (MIFR) also serves as a clinically useful predictor of the MVV. A total of 105 subjects, 45 women and 60 men (age 57 ± 5 yr, mean ± SD), with expiratory impairment categories of severe (n = 26), moderate (n = 22), mild (n = 18), and normal (n = 39) based on FEV1 (percentage of predicted), comprised the study samples. The ratio MVV/FEV1 averaged 41 ± 7 overall. The FEV1 correlated with MVV in normal subjects (p < 0.05, r2 = 0.642) and patients (p < 0.05, r2 = 0.787) better than MIFR (p < 0.05, r2 ≥ 0.480). MIFR joined with FEV1 in multiple linear regression to significantly improve the description of MVV: MVV L/min = 30.77FEV1 (L) + 5.94MIFR (L/s) - 4.77 (n = 105; p < 0.05, r2 = 0.849). The 95{\%} confidence limits for MVV varied from 90 to 110{\%} of predicted from the equation for this sample. The factors sex and impairment category did not reduce the unexplained variability in MVV after inclusion of FEV1 and MIFR as covariates in ANOVA (p > 0.05). Addition of MIFR to the model with FEV1 produced greater improvement in r2 than PI(max). We conclude that MIFR, although secondary in importance to FEV1, is a significant determinant of MVV in patients with COPD and normal subjects. Estimation of MVV from FEV1 alone is less accurate than either direct measurement of MVV or estimation by inclusion of MIFR.",
author = "Dillard, {Thomas A} and Hnatiuk, {O. W.} and McCumber, {T. R.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1164/ajrccm/147.4.870",
language = "English (US)",
volume = "147",
pages = "870--875",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Maximum voluntary ventilation

T2 - Spirometric determinants in chronic obstructive pulmonary disease patients and normal subjects

AU - Dillard, Thomas A

AU - Hnatiuk, O. W.

AU - McCumber, T. R.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The 12-s maximum voluntary ventilation (MVV) provides an estimate of the ventilatory reserves available to meet the physiologic demands of exercise. Earlier studies established a general relationship between MVV and FEV1. We hypothesized that the resting maximum inspiratory flow rate (MIFR) also serves as a clinically useful predictor of the MVV. A total of 105 subjects, 45 women and 60 men (age 57 ± 5 yr, mean ± SD), with expiratory impairment categories of severe (n = 26), moderate (n = 22), mild (n = 18), and normal (n = 39) based on FEV1 (percentage of predicted), comprised the study samples. The ratio MVV/FEV1 averaged 41 ± 7 overall. The FEV1 correlated with MVV in normal subjects (p < 0.05, r2 = 0.642) and patients (p < 0.05, r2 = 0.787) better than MIFR (p < 0.05, r2 ≥ 0.480). MIFR joined with FEV1 in multiple linear regression to significantly improve the description of MVV: MVV L/min = 30.77FEV1 (L) + 5.94MIFR (L/s) - 4.77 (n = 105; p < 0.05, r2 = 0.849). The 95% confidence limits for MVV varied from 90 to 110% of predicted from the equation for this sample. The factors sex and impairment category did not reduce the unexplained variability in MVV after inclusion of FEV1 and MIFR as covariates in ANOVA (p > 0.05). Addition of MIFR to the model with FEV1 produced greater improvement in r2 than PI(max). We conclude that MIFR, although secondary in importance to FEV1, is a significant determinant of MVV in patients with COPD and normal subjects. Estimation of MVV from FEV1 alone is less accurate than either direct measurement of MVV or estimation by inclusion of MIFR.

AB - The 12-s maximum voluntary ventilation (MVV) provides an estimate of the ventilatory reserves available to meet the physiologic demands of exercise. Earlier studies established a general relationship between MVV and FEV1. We hypothesized that the resting maximum inspiratory flow rate (MIFR) also serves as a clinically useful predictor of the MVV. A total of 105 subjects, 45 women and 60 men (age 57 ± 5 yr, mean ± SD), with expiratory impairment categories of severe (n = 26), moderate (n = 22), mild (n = 18), and normal (n = 39) based on FEV1 (percentage of predicted), comprised the study samples. The ratio MVV/FEV1 averaged 41 ± 7 overall. The FEV1 correlated with MVV in normal subjects (p < 0.05, r2 = 0.642) and patients (p < 0.05, r2 = 0.787) better than MIFR (p < 0.05, r2 ≥ 0.480). MIFR joined with FEV1 in multiple linear regression to significantly improve the description of MVV: MVV L/min = 30.77FEV1 (L) + 5.94MIFR (L/s) - 4.77 (n = 105; p < 0.05, r2 = 0.849). The 95% confidence limits for MVV varied from 90 to 110% of predicted from the equation for this sample. The factors sex and impairment category did not reduce the unexplained variability in MVV after inclusion of FEV1 and MIFR as covariates in ANOVA (p > 0.05). Addition of MIFR to the model with FEV1 produced greater improvement in r2 than PI(max). We conclude that MIFR, although secondary in importance to FEV1, is a significant determinant of MVV in patients with COPD and normal subjects. Estimation of MVV from FEV1 alone is less accurate than either direct measurement of MVV or estimation by inclusion of MIFR.

UR - http://www.scopus.com/inward/record.url?scp=0027458884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027458884&partnerID=8YFLogxK

U2 - 10.1164/ajrccm/147.4.870

DO - 10.1164/ajrccm/147.4.870

M3 - Article

VL - 147

SP - 870

EP - 875

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -